EPISODE · Dec 8, 2008 · 4 MIN
Icon boosts bioanalytical presence through Prevalere buy
from Outsourcing-Pharma Podcast · host William Reed Ltd
Icon's recent $43.2m acquisition of New York-based Prevalere Life Sciences is the latest part of the firm's expansion in the US CRO market. Outsourcing-Pharma spoke with Icon's VP of bioanalytical development, Brian O'Dwyer, and Prevalere CEO Mario Rocci from a busy AAPS conference in Atlanta.
Embed this episode
NOW PLAYING
Icon boosts bioanalytical presence through Prevalere buy
0:00
4:24
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Outsourcing-Pharma Podcast?
This episode is 4 minutes long.
When was this Outsourcing-Pharma Podcast episode published?
This episode was published on December 8, 2008.
Can I download this Outsourcing-Pharma Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!